Evidence map›Paper›PMID 37019973›Full record

ArticleNature communications2023

Role of TMEM100 in mechanically insensitive nociceptor un-silencing.

Timo A Nees, Na Wang, Pavel Adamek, Nadja Zeitzschel, Clement Verkest, Carmen La Porta, Irina Schaefer, Julie Virnich, Selin Balkaya, Vincenzo Prato and 8 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 5 countries.

Timo A NeesInstitute of Pharmacology, Heidelberg University, Heidelberg, Germany.
Na WangInstitute of Pathophysiology, Yan'an University, Yan'an, China.
Pavel AdamekDepartment of Anesthesiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0002-7131-6016
Nadja ZeitzschelDepartment of Anesthesiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0003-4332-7049
Clement VerkestDepartment of Anesthesiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Carmen La PortaInstitute of Pharmacology, Heidelberg University, Heidelberg, Germany.
Irina SchaeferInstitute of Pharmacology, Heidelberg University, Heidelberg, Germany.
Julie VirnichDepartment of Anesthesiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0001-7917-9012
Selin BalkayaDepartment of Anesthesiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Vincenzo PratoInstitute of Pharmacology, Heidelberg University, Heidelberg, Germany.
Chiara MorelliSISSA: Scuola Internazionale Superiore di Studi Avanzati, Trieste, Italy.
Valerie BegayDepartment of Neuroscience, Max Delbrück Center for Molecular Medicine, Berlin, Germany.
Young Jae LeeDepartment of Biochemistry, Lee Gil Ya Cancer and Diabetes Institute, Gachon University College of Medicine, Incheon, Republic of Korea.ORCID 0000-0002-3841-1994
Anke Tappe-TheodorInstitute of Pharmacology, Heidelberg University, Heidelberg, Germany.ORCID 0000-0002-9343-7580
Gary R LewinDepartment of Neuroscience, Max Delbrück Center for Molecular Medicine, Berlin, Germany.ORCID 0000-0002-2890-6352
Paul A HeppenstallSISSA: Scuola Internazionale Superiore di Studi Avanzati, Trieste, Italy.
Francisco J TabernerInstitute of Pharmacology, Heidelberg University, Heidelberg, Germany.
Stefan G LechnerInstitute of Pharmacology, Heidelberg University, Heidelberg, Germany. s.lechner@uke.de.ORCID 0000-0001-9402-9127
Universität Hamburg · DEHeidelberg University · DEMax Delbrück Center · DEScuola Internazionale Superiore di Studi Avanzati · ITGachon University · KRUniversitat de Miguel Hernández d'Elx · ESYan'an University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mechanically silent nociceptors are sensory afferents that are insensitive to noxious mechanical stimuli under normal conditions but become sensitized to such stimuli during inflammation. Using RNA-sequencing and quantitative RT-PCR we demonstrate that inflammation upregulates the expression of the transmembrane protein TMEM100 in silent nociceptors and electrophysiology revealed that over-expression of TMEM100 is required and sufficient to un-silence silent nociceptors in mice. Moreover, we show that mice lacking TMEM100 do not develop secondary mechanical hypersensitivity-i.e., pain hypersensitivity that spreads beyond the site of inflammation-during knee joint inflammation and that AAV-mediated overexpression of TMEM100 in articular afferents in the absence of inflammation is sufficient to induce mechanical hypersensitivity in remote skin regions without causing knee joint pain. Thus, our work identifies TMEM100 as a key regulator of silent nociceptor un-silencing and reveals a physiological role for this hitherto enigmatic afferent subclass in triggering spatially remote secondary mechanical hypersensitivity during inflammation.

Indexed as

NociceptorsPainAnimalsInflammationKnee JointMembrane ProteinsMiceSkinMembrane ProteinsTmem100 protein, mouse

Identifiers

PMID37019973
PMCPMC10076432
OpenAlexW4362634622

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.